Eltrombopag-olamine
| Eltrombopag-olamine | |
|---|---|
| Term | Eltrombopag-olamine |
| Short definition | eltrombopag-olamine (el-TROM-boh-pag OH-luh-meen) A drug used to treat thrombocytopenia (low blood platelet count) in adults and children with chronic immune thrombocytopenic purpura caused by other treatments didn't get better. Eltrombopag olamine is also used to treat severe aplastic anemia. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
eltrombopag-olamine - (pronounced) (el-TROM-boh-pag OH-luh-meen) A drug used to treat thrombocytopenia (low blood platelet count) in adults and children with chronic immune thrombocytopenic purpura caused by other treatments didn't get better. Eltrombopag olamine is also used to treat severe aplastic anemia. It is also being studied in the treatment of other diseases and cancers. Eltrombopag olamine binds to the thrombopoietin receptor, causing the bone marrow to make more platelets. It is a type of thrombopoietin receptor agonist. Also called Promacta
External links
- Medical encyclopedia article on Eltrombopag-olamine
- Wikipedia's article - Eltrombopag-olamine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski